acid, both known precursors of NAD and that, with the special need for efficient ethanol metabolism, they may even have an above normal requirement for this cofactor. Consequently, in the chronic alcoholic, there is supra-efficient conversion of available tryptophan to NAD in the presence of adequate B8 and that the result is less than normal amounts of the intermediate metabolites are excreted after a tryptophan load. One of the determining factors in such a situation may be a thiamine deficiency which is known to stimulate pyrrolase and this enzyme determines the amount of tryptophan channelled into the nicotinic acid pathway. (Quagliariello, 1963) . Minor degrees of thiamine deficiency are known to be common in chronic alcoholics.
In conclusion it appears that the tryptophan loading test as an index of human pyridoxine deficiency is not satisfactory because it does not become abnormal until P-pallevels are less than 20 %of normal.
Standards. Calibration curves were made by the same two workers at the start of the series and repeated during the time the "kit" was being used. The calibration curves given by the Sigma and Boehringer "kits" agreed and showed little change or "drift" during the lifetime of the "kit." Hyland and Staynes "kits" also gave similar curves but showed more "drift" during the period in which the "kit" was used.
Sera. The sera of 46 patients were tested by all four "kits" and the mean of the results are given Of the estimation of enzyme levels, the determination of the transaminases-L-alanine-2oxoglutarate aminotransferase (GPT) and Laspatate-2-oxoglutarate aminotransferase (GOT) -is probably the most common and the "kit" outfits available for these assays have been compared. Since their introduction about eight years ago, Four "kits" were available for the GPT "Kit Outfits" (i.e. the commercial supply of all estimations and five for the GOT. Details of the necessary solutions, ready for use) for the prices, times of estimation, ranges of assay and estimation of enzyme levels have become increas-normal serum ranges are given in Table J . ingly used. As most laboratories determine some Determinations by all the "kits" were made on of their assays of enzymes by these outfits, at a the same sera at the same time by the same two cost of many thousands of pounds, the supply workers, using the methods exactly as given in of these has become important commercially the manufacturers literature and the sera were and now several firms in Britain, U.S.A., chosen to avoid the necessity for dilution. Sweden and Germany manufacture them.
Experience has shown that different "kits" have given different results when applied to the same serum. Since, in recent years, the use of enzyme determinations as diagnostic tests has increased greatly and there is much difficulty in interpreting "borderline" results, it is necessary to examine critically not only the methods but also the solutions in use. The calibration curves obtained by the two workers were in agreement in two of the "kits" (Sigma and Staynes) and slightly different in one (Boehringer) and showed little change during the period of the test. However, in two "kits," TransAc and Hyland, different curves were obtained. In the preparation of these curves, both workers prepared their GPT determinations by "Kit" Outfits (Means of 46 determinations. RF Units). in Table II . Little difference was observed. Of tests on 50 sera done consecutively the results were in agreement, either all normal or all raised, in 47 and in only three was a very slight disagreement given by one "kit." It was concluded that in no case would the use of any particular "kit" result in error of diagnostic significance. GOT Determinations. Five "kits" were tested, those of Boehringer, Hyland, Sigma, Staynes and TransAc.
DisausioD
The use of any of the "kit" outfits for the TABLE II respective "TransAc" chromagen with colour developer tablets supplied by the firm and similarly two separate dilutions of the concentrated NaOH supplied in the Hyland "kit" were used. Both calibration curves showed considerable drift during the "lifetime" of the kit (Fig. 1) . At the extreme range given by the different calibration curves, a single reading of optical density of 0.35 would indicate a difference of up to 40 R.F. units. Sera. The sera of 46 patients were tested by all "kits" and the mean of the results given in Table  III . The results of three "kits" are in agreement but the results given by the other two differ significantly-Staynes being low and Boehringer, high. In a series of tests on 50 sera, the results in 32 were in agreement and in ten slight disagreement was noted, but in 8 (16%) there were serious discrepancies. (Table IV) . In these cases, an error of some significance in the diagnosis might be made. Some examples of the results on individual sera are given in Table V , where it will be seen that the serum of patients 1 and 2 gave raised levels with four of the five "kits" and normal with the other but the "kit" giving the normal value differed. Patients numbers 6 and 7 gave normal values with three of the five "kits" and raised values with the other two, again the "kits" giving the raised levels were different.
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(Shaded area-drift of curve during period in which "Kit" was used.). determination of GPT activity, as indicated by this study, would probably lead to no error in the determination of normal or abnormal serum GPT levels and it is probable that the results obtained in different laboratories using these "kits" would be comparable.
Results of GOT determinations on
However, differences would be encountered in the determination of serum GOT levels by the "kits" used in this study. In 16% of the sera tested, the difference was sufficient to be of diagnostic importance and might lead to an error in diagnosis. No one "kit" can be singled out as being at fault and no explanation for the .. difference can be offered but slight variations in the solutions and ageing of the reagents have considerable effect on the results. It is evident that the results given by one "kit" cannot be " compared with the results of the other GOT "kits" and the results obtained by different ·3 laboratories are not comparable.
As all the tests, reported in this paper, were ·2 carried out under "research" conditions, it is possible that even greater differences would be .. met when the tests were performed in the rush of a busy "routine service" laboratory. 22 20 43 Finally one must be aware of "operator bias." A foreknowledge of the type of compound, and the reaction of its analogues, may lead to exaggeration of trivial deviations from normal which may be due to changes in environment, analytical drift, etc.
The actual procedure for drug safety assessment falls into four main stages:
(a) acute toxicity tests. These provide information about the relative toxicity compared with other compounds and give preliminary information which helps to set dose limits for longterm studies.
(b) initial short-term studies. These are designed in most cases to provide safety clearance for the administration of one dose of the compound to human volunteers so that metabolism, blood level and excretion studies can be commenced. Such short-term tests are generally carried out in rats and dogs of both sexes. The drug is administered daily to different dosage groups and during the period full hsematological and biochemical studies are carried out as well as regular observations on weight gain and growth patterns. At the end of the test period terminal samples are taken for biochemical and hematological studies, the animals are autopsied and major organs removed and evaluated by the histopathologist.
(c) if the initial work is satisfactory and the compound is to proceed to clinical trial, lengthy toxicity tests will be initiated. The test period The prime function of our toxicology unit is White rabbits, but not in New Zealand Grey to detect any adverse reactions to proposed new rabbits. One must therefore try to choose a drugs or formulations in laboratory animals at strain which is suitable for the particular test the earliest possible stage, no matter how trivial under consideration. these reactions may seem. Such information cannot be directly extrapolated to man, but can indicate to the clinician the possible ways in which toxic reactions may manifest themselves.
In conducting any animal toxicity test or interpreting the data obtained from such tests, the toxicologist is faced with certain problems, and he must be aware of these in order to reach any valid conclusions. Firstly, a detailed knowledge of the "normal" animal and the limits of variation from the norm must be obtained in order to appreciate significant variations from these values. With the introduction of a new species and new strains of animals, the need for more control information is ever increasing. Secondly, the choice of animal species is importand. Ideally, the animal of choice should metabolise the drug in the same way as man. This involves close co-operation with the Biochemistry Section, who are involved in metabolism and excretion studies, and may necessitate the use of an alternate species of animals.
There are many examples of species variation in the reactions to a particular drug; for example one compound which will produce gross methemoglobinemia in the cat within It hours after the administration of one dose of 25 mg.fkg, produces only a trace of methemoglobinemia in the rat 6-10 hours following a dose 50-100 times that given to the cat.
Strain variation within species can present further problems, e.g. thalidomide will produce foetal deformities in pregnant New Zealand It is concluded that in the use of "kit" outfits for the assay of enzyme activity, it is essential to: (1) establish one's own normal range with the "kit" used; (2) repeat the calibration curves frequently; (3) use known serum controls and blanks daily and (4) ascertain that the solutions supplied are really stable for the period stated by the manufacturers.
